Metabolex, Inc.

DCC mediated coupling for halofenate manufacture

#2 | 2014-05-08

US20140128439A1

Methods for Treating Gout Flares

#3 | 2014-05-01

US20140121246A1

GPR120 RECEPTOR AGONISTS AND USES THEREOF

#4 | 2014-02-06 ✅ Patent 8,815,886 granted on 2014-08-26

US20140038971A1

Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts

#5 | 2014-01-23 ✅ Patent 8,993,797 granted on 2015-03-31

US20140024852A1

Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto

#6 | 2013-05-23 ✅ Patent 8,598,374 granted on 2013-12-03

US20130131351A1

GPR120 receptor agonists and uses thereof

#7 | 2013-05-02 ✅ Patent 8,476,308 granted on 2013-07-02

US20130109734A1

GPR120 receptor agonists and uses thereof

#8 | 2012-09-13 ✅ Patent 8,507,719 granted on 2013-08-13

US20120232303A1

Crystalline solid and amorphous forms of (−)-halofenate and methods related thereto

#9 | 2012-09-06 ✅ Patent 8,481,597 granted on 2013-07-09

US20120225940A1

Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia

#10 | 2011-12-22 ✅ Patent 8,299,117 granted on 2012-10-30

US20110313003A1

GPR120 receptor agonists and uses thereof

#11 | 2011-12-01

US20110294836A1

ARYL GPR119 AGONISTS AND USES THEREOF

#12 | 2011-06-23 ✅ Patent 8,410,127 granted on 2013-04-02

US20110152270A1

Substituted tetrazol-1-yl-phenoxymethyl-thiazol-2-yl-piperidinyl-pyrimidine salts

#13 | 2010-07-29 ✅ Patent 8,309,600 granted on 2012-11-13

US20100190831A1

GPR120 receptor agonists and uses thereof

#14 | 2010-06-17

US20100152295A1

METHODS OF REDUCING SMALL, DENSE LDL PARTICLES

#15 | 2010-05-27 ✅ Patent 8,288,384 granted on 2012-10-16

US20100130511A1

Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

#16 | 2010-04-15 ✅ Patent 8,329,749 granted on 2012-12-11

US20100093855A1

Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia

#17 | 2010-04-15 ✅ Patent 8,541,614 granted on 2013-09-24

US20100093854A1

Process for the preparation of (−)-(4-chloro-phenyl)-(3-trifluoromethyl-phenoxy)-acetic acid 2-acetylamino-ethyl ester

#18 | 2010-04-15 ✅ Patent 8,354,448 granted on 2013-01-15

US20100093853A1

Use of (−)(3-trihalomethylphenoxy)(4-halophenyl) acetic acid derivatives for treatment of type 2 diabetes

#19 | 2010-04-08

US20100087468A1

MODULATORS OF PPAR AND METHODS OF THEIR PREPARATION

#20 | 2010-04-08 ✅ Patent 8,227,495 granted on 2012-07-24

US20100087465A1

2,4-disubsituted thiazoles and pharmaceutical compositions thereof

#21 | 2009-08-18 ✅ Patent 7,576,131 granted on 2009-08-18

US10382186

Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, type 2 diabetes, hyperlipidemia and hyperuricemia

#22 | 2009-05-28 ✅ Patent 8,183,381 granted on 2012-05-22

US20090137590A1

N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders

#23 | 2009-04-09

US20090093650A1

RESOLUTION OF ALPHA-(PHENOXY)PHENYLACETIC ACID DERIVATIVES WITH NAPHTHYL-ALKYLAMINES

#24 | 2009-03-31 ✅ Patent 7,510,851 granted on 2009-03-31

US10321204

Compositions and methods for diagnosing and treating diabetes, insulin resistance and dyslipidemia

#25 | 2009-02-26 ✅ Patent 7,638,541 granted on 2009-12-29

US20090054475A1

5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine

#26 | 2008-12-25

US20080318312A1

PANCREATIC ISLET TRANSCRIPTION FACTOR AND USES THEREOF

#27 | 2008-11-20

US20080287441A1

ALPHA-(TRIFLUOROMETHYL-SUBSTITUTED ARYLOXY, ARYLAMINO, ARYLTHIO OR ARYLMETHYL)-TRIFLUOROMETHYL-SUBSTITUTED PHENYLACETIC ACIDS AND DERIVATIVES AS ANTIDIABETIC AGENTS

#28 | 2008-10-30 ✅ Patent 8,288,438 granted on 2012-10-16

US20080269189A1

Methods for avoiding edema in the treatment or prevention of PPARγ-responsive diseases, including cancer

#29 | 2008-10-09

US20080248010A1

Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)

#30 | 2008-09-11 ✅ Patent 8,203,019 granted on 2012-06-19

US20080221018A1

Crystalline solid and amorphous forms of (−)- halofenate and methods related thereto

#31 | 2008-05-08

US20080108630A1

SUBSTITUTED TRIAZOLES AS MODULATORS OF PPAR AND METHODS OF THEIR PREPARATION

#32 | 2008-03-13

US20080064857A1

Electricity

Methods and Reagents for Diagnosis and Treatment of Diabetes

#33 | 2007-11-22

US20070270490A1

USE OF (-)(3-TRIHALOMETHYLPHENOXY)(4-HALOPHENYL) ACETIC ACID DERIVATIVES FOR TREATMENT OF INSULIN RESISTANCE, TYPE 2 DIABETES AND HYPERLIPIDEMIA

#34 | 2007-08-30

US20070203243A1

RESOLUTION OF ALPHA-(PHENOXY) PHENYLACETIC ACID DERIVATIVES

#35 | 2007-03-29 ✅ Patent 7,432,394 granted on 2008-10-07

US20070073082A1

Resolution of α-(phenoxy) phenylacetic acid derivatives with naphthyl-alkylamines

#36 | 2007-03-29 ✅ Patent 7,714,131 granted on 2010-05-11

US20070072858A1

Process for the stereoselective preparation of (−)-halofenate and derivatives thereof

#37 | 2007-03-08 ✅ Patent 7,294,698 granted on 2007-11-13

US20070055050A1

Methods and reagents for diagnosis and treatment of diabetes

#38 | 2007-02-08

US20070031897A1

Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRP

#39 | 2006-12-28

US20060292563A1

Methods of diagnosing & treating diabetes and insulin resistance

#40 | 2006-12-05 ✅ Patent 7,144,985 granted on 2006-12-05

US10308393

Methods and reagents for diagnosis and treatment of diabetes

#41 | 2006-11-23 ✅ Patent 7,642,358 granted on 2010-01-05

US20060264630A1

Substituted phenylacetic acids

#42 | 2006-11-23 ✅ Patent 7,405,289 granted on 2008-07-29

US20060264611A1

Pancreatic islet transcription factor and uses thereof

#43 | 2006-11-09 ✅ Patent 7,344,844 granted on 2008-03-18

US20060252100A1

Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)

#44 | 2006-11-02 ✅ Patent 7,556,930 granted on 2009-07-07

US20060246006A1

CD39L3 and its role in diabetes

#45 | 2006-10-12

US20060228706A1

Methods of diagnosing and treating diabetes and insulin resistance

#46 | 2006-09-21

US20060210974A1

Compositions and methods for preventing, treating and diagnosing diabetes

#47 | 2006-08-08 ✅ Patent 7,087,394 granted on 2006-08-08

US10794897

Methods and compositions for treating and diagnosing diabetes and related diseases involving beta-TRP

#48 | 2006-07-18 ✅ Patent 7,078,421 granted on 2006-07-18

US10394487

Substituted phenylacetic acids

#49 | 2006-07-06 ✅ Patent 7,491,533 granted on 2009-02-17

US20060148037A1

Polynucleotides encoding an isolated β-islet cell two-pore domain potassium channel

#50 | 2006-05-30 ✅ Patent 7,053,180 granted on 2006-05-30

US10459190

Isolated islet beta-cell two-pore domain potassium channel

#51 | 2006-04-06

US20060074018A1

Methods of diagnosing & treating diabetes and insulin resistance

#52 | 2006-03-16 ✅ Patent 7,622,491 granted on 2009-11-24

US20060058301A1

Modulators of PPAR and methods of their preparation

#53 | 2006-01-19 ✅ Patent 7,323,480 granted on 2008-01-29

US20060014809A1

Substituted triazoles as modulators of PPAR and methods of their preparation

#54 | 2006-01-19

US20060014785A1

BICYCLIC, SUBSTITUTED TRIAZOLES AS MODULATORS OF PPAR AND METHODS OF THEIR PREPARATION

#55 | 2005-10-20 ✅ Patent 7,109,021 granted on 2006-09-19

US20050233347A1

Compositions and methods of using apoptosis signaling kinase related kinase (ASKRK)

#56 | 2005-10-06 ✅ Patent 7,371,888 granted on 2008-05-13

US20050222213A1